Pacira BioSciences

Yahoo Finance • 2 days ago

PharmaCorp Rx Inc. Files Preliminary Short Form Base Shelf Prospectus

SASKATOON, Saskatchewan, Sept. 29, 2025 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV:PCRX) is pleased to announce that it has filed a preliminary short form base shelf prospectus with the securities co... Full story

Yahoo Finance • 23 days ago

PharmaCorp to Acquire a Pharmacy in Ontario for $5,300,000, New Non-Binding Letter of Intent to Acquire Two Pharmacies in Eastern Canada, Updates on Previously Announced Non-Binding Letters of Intent and Filing of Q2 Investor Presentation

SASKATOON, Saskatchewan, Sept. 08, 2025 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) is pleased to announce the signing of a definitive share purchase agreement to acquire a 100% interest in a P... Full story

Yahoo Finance • 26 days ago

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BRISBANE, Calif., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of patients, today announced the granting o... Full story

Yahoo Finance • 28 days ago

PharmaCorp to Acquire Two Pharmacies in Western Canada

SASKATOON, Saskatchewan, Sept. 03, 2025 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) is pleased to announce that it has entered into definitive share purchase agreements, each dated August 29, 2... Full story

Yahoo Finance • 2 months ago

PharmaCorp Rx Inc. Reports Q2 2025 Financial Results

SASKATOON, Saskatchewan, Aug. 15, 2025 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) a growing national platform for pharmacist-led community pharmacy ownership, today reported its financial resu... Full story

Yahoo Finance • 2 months ago

PharmaCorp Rx Inc. Announces New Credit Facilities With CIBC and Unveils Pharmacist Co-Ownership Financing Initiative

SASKATOON, Saskatchewan, Aug. 13, 2025 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) is pleased to announce that it has entered into a credit agreement with Canadian Imperial Bank of Commerce (“C... Full story

Yahoo Finance • 2 months ago

PACIRA BIOSCIENCES INC (NASDAQ:PCRX) Emerges as a Strong Value Investing Opportunity

Value investing is a method that looks for stocks trading below their true worth, providing a safety net for investors. One approach to finding these opportunities is by checking companies with solid basics, especially in valuation, profit... Full story

Yahoo Finance • 2 months ago

PharmaCorp Completes Acquisition of a Pharmacy in Western Canada

SASKATOON, Saskatchewan, Aug. 07, 2025 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) is pleased to announce that, further to its news release dated June 26, 2025, it has completed the acquisition... Full story

Yahoo Finance • 2 months ago

Pacira outlines narrowed $730M–$750M revenue guidance and increased margin targets as J&J ZILRETTA partnership takes shape

Earnings Call Insights: Pacira BioSciences (PCRX) Q2 2025 MANAGEMENT VIEW * Frank D. Lee, CEO, reported progress across corporate, clinical, and commercial initiatives, stating, "The stage is set for accelerating top line growth in the... Full story

Yahoo Finance • 2 months ago

Pacira BioSciences Inc (NASDAQ:PCRX) Reports Mixed Q2 2025 Earnings with EPS Beat but Revenue Miss

Pacira BioSciences Inc (NASDAQ:PCRX [https://www.chartmill.com/stock/quote/PCRX]) reported its second-quarter 2025 financial results, delivering a mixed performance relative to analyst expectations. While earnings per share (EPS) slightly... Full story

Yahoo Finance • 3 months ago

Pacira BioSciences Gene Therapy Shows Sustained Knee Osteoarthritis Improvement

Pacira BioSciences Inc. (NASDAQ:PCRX) is one of the most undervalued small-cap stocks to buy according to analysts. On June 11, Pacira BioSciences announced new long-term follow-up data from its Phase 1 clinical trial of PCRX-201 (enekinra... Full story

Yahoo Finance • 3 months ago

PharmaCorp to acquire Western Canada pharmacy for $2.4 million

SASKATOON - PharmaCorp Rx Inc. (TSXV:PCRX), a pharmaceutical retailer with a market capitalization of $1.1 billion and annual revenues of $703 million, has agreed to acquire a PharmaChoice Canada bannered pharmacy in Western Canada for $2.... Full story

Yahoo Finance • 3 months ago

Pacira BioSciences Debuts Inspiring New Film Highlighting One Patient’s Journey to Pain Relief and Innovation in Care at BIO 2025

- Produced for Pacira by BBC StoryWorks Commercial Productions, The Next Frontier: Mark & Leah’s Story Highlights the Impact of Non-Opioid Solutions - BRISBANE, Calif., June 18, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ:... Full story

Yahoo Finance • 3 months ago

PACIRA ALERT: Bragar Eagel & Squire, P.C. is Investigating Pacira BioSciences, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

NEW YORK, June 17, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Pacira BioSciences, Inc. (NASDAQ:PCRX) on behalf of long-term stockho... Full story

Yahoo Finance • 4 months ago

Grabar Law Office Investigates Claims on Behalf of Shareholders of DoubleVerify Holdings, Inc. (NYSE: DV); NAPCO Securities Technologies, Inc. (NASDAQ: NSSC); Pacira Biosciences, Inc. (NASDAQ: PCRX); and Treace Medical Concepts, Inc. (NASDAQ: TMCI)

PHILADELPHIA, May 26, 2025 (GLOBE NEWSWIRE) -- DoubleVerify Holdings, Inc. (NYSE: DV): If you have held DoubleVerify Holdings, Inc. (NYSE: DV) shares since prior to November 10, 2023, and would like to learn more about the investigatio... Full story

Yahoo Finance • 5 months ago

Pacira BioSciences to Participate in Fireside Chat at Two Upcoming Healthcare Conferences

BRISBANE, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that i... Full story

Yahoo Finance • 5 months ago

Pacira BioSciences to Present 104-Week Efficacy Data Following a Single Local Administration of PCRX-201 for Patients with Mild to Severe Osteoarthritis of the Knee

-- Poster to be presented at OARSI World Congress on Osteoarthritis -- BRISBANE, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid... Full story

Yahoo Finance • 5 months ago

Pacira BioSciences Reaffirms Commitment to Enhancing Value for All Shareholders

-- $300 million aggregate share repurchase authorization-- -- Reinforces confidence in 5x30 plan – -- Continued focus on margin expansion and operational efficiency -- BRISBANE, Calif., April 17, 2025 (GLOBE NEWSWIRE) -- Pacira BioSci... Full story

Yahoo Finance • 6 months ago

Pacira BioSciences Announces Settlement of U.S. Patent Litigation for EXPAREL

-- Fresenius Kabi licensed to sell volume-limited amounts of generic bupivacaine liposome injectable suspension in the U.S. no earlier than a confidential date in 2030 -- -- Fresenius also licensed to sell generic bupivacaine liposome inj... Full story

Yahoo Finance • 7 months ago

Pacira BioSciences Confirms Receipt of Director Nominations from DOMA Perpetual

-- No Shareholder Action Required at This Time -- PARSIPPANY, N.J., March 14, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to tr... Full story